-+ 0.00%
-+ 0.00%
-+ 0.00%

FibroBiologics Reports Preclinical Data Showing FSdC Spheroids Best Preserve Disc Height In Rabbit Degenerative Disc Disease Model

Benzinga·10/19/2026 12:36:02
Diffusion vocale

FSdC Spheroids Preserved Disc Height Better Than Any Other Fibroblast-Based Approach Tested in a 12-Week Rabbit Model of Degenerative Disc Disease

HOUSTON, Oct. 19, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Nikolay Bazhanov, M.D., Ph.D. presented preclinical data on the Company's fibroblast spheroid-derived chondrocyte (FSdC) spheroids for degenerative disc disease (DDD) at the North American Spine Society (NASS) 2026 Annual Meeting, taking place October 14-17 in San Antonio.